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Célkitûzés – Korábbi kutatások alapján a tünetészleléshez
és a különféle idiopathiás környezeti intoleranciákhoz két
vonásjellegû jellemzô, a szomatoszenzoros amplifikáció és
az abszorpció is kapcsolódik.
Kérdésfelvetés – Mivel a két vonás kevés átfedést mutat
egymással, feltételezhetô egyrészt az, hogy függetlenül
járulnak hozzá mind a tünetek észleléséhez, mind az
elektro mágneses hiperszenzitivitáshoz, másrészt az is,
hogy kölcsönhatásba léphetnek egymással.
A vizsgálat módszere – Online kérdôíves vizsgálat.
A vizsgálat alanyai – 506 egyetemi hallgató töltött ki egy
kérdôívcsomagot, ami a szomatoszenzoros amplifikációs
tendenciát, az abszorpciót, a negatív affektivitást, a min-
dennapi testi tüneteket, valamint az elektromágneses
hiperszenzitivitást mérte.
Eredmények – A lineáris regressziós elemzésben mind a
szomatoszenzoros amplifikáció (β = 0,170, p < 0,001),
mind az abszorpció (β = 0,128, p < 0,001) kapcsolódott
a mindennapi tünetekhez, a nem és a negatív affektivitás
kontrollálását követôen is (R2 = 0,347, p < 0,001). Mind
a szomatoszenzoros amlifikáció (OR = 1,082, p < 0,05),
mind az abszorpció (OR = 1,079, p < 0,01) szignifikán-
san hozzájárult az elektromágneses hiperszenzitivitáshoz a
testi tünetek, a nem és a negatív affektivitás kontrollálását
követôen is (bináris logisztikus regressziós elemzés,
Nagelkerke R2 = 0,134, p < 0,001). Interakciós hatást
egyik elemzésben sem találtunk.
Következtetések – A szomatoszenzoros amplifikáció és
az abszorpció egymástól függetlenül járulnak hozzá a
tünetészleléshez. A tünetriportok és az elektromágneses
hiperszenzitivitás mögött többféle pszichológiai mechaniz-
mus húzódhat meg.
Kulcsszavak: abszorpció, szomatoszenzoros amplifikáció,
elektromágneses hiperszenzitivitás, nocebo, orvosilag 
megmagyarázatlan tünetek
Background – Two trait-like characteristics, somatosenso-
ry amplification and absorption, have been associated
with symptom reports and idiopathic environmental intol-
erances in past research. 
Purpose – As the two constructs are not connected with
each other, their independent contribution to symptom
reports and electromagnetic hypersensitivity, as well as
their interaction can be expected. 
Methods – On-line questionnaire. 
Patients – 506 506 college students completed an on-line
questionnaire assessing absorption, somatosensory ampli-
fication, negative affect, somatic symptoms, and electro-
magnetic hypersensitivity. 
Results – Somatosensory amplification (β = 0.170, p <
0.001) and absorption (β = 0.128, p < 0.001) independ-
ently contributed to somatic symptoms after controlling for
gender and negative affect (R2 = 0.347, p < 0.001).
Similarly, somatosensory amplification (OR = 1.082, p <
0.05) and absorption (OR = 1.079, p < 0.01) independ-
ently contributed to electromagnetic hypersensitivity after
controlling for somatic symptoms, gender, and negative
affect (Nagelkerke R2 = 0.134, p < 0.001). However, no
interaction effects were found. 
Discussion – Somatosensory amplification and absorption
independently contribute to symptom reports and electro-
magnetic hypersensitivity.
Conclusion – The findings suggest that psychological
mechanisms underlying symptom reports and electromag-
netic hypersensitivity might be heterogeneous.
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Aconsiderable proportion of symptoms thatpatients report to their physicians cannot be
explained by pathophysiological processes, and
thus are considered medically unexplained symp-
toms (MUS)1, 2. For the cases when MUS show
characteristic patterns and become chronic, such as
chronic fatigue syndrome and fibromyalgia, the
term functional somatic syndromes was proposed1.
The overlaps among these syndromes with respect
to symptoms and comorbidities are so large that
their integration into a single diagnostic category
was also suggested3. 
Idiopathic environmental intolerances (IEI) can
be regarded as a facet of MUS4. Their most distinct
feature is that symptoms are attributed to various
environmental factors (e.g. chemicals or electro-
magnetic fields) which do not impact the majority
of the population. This is why these conditions have
originally been called hypersensitivities, e.g. multi-
ple chemical hypersensitivity or electromagnetic
hypersensitivity. Later, as provocation studies did
not support the causal role of the suspected factors
in the maintenance of the respective conditions5, 6,
the use of the etiologically more neutral idiopathic
environmental intolerance was suggested7. Re -
search in the area today focuses primarily on possi-
ble psychological (top-down) etiological factors,
for example classical conditioning or expectations
(nocebo phenomenon)8, 9.
As the impact of psychological factors on MUS
appears substantial, exploration of stable (trait-like)
personality characteristics that are reliably associated
with these conditions might be helpful to better under-
stand the phenomenon. Two characteristics related to
symptom reports are female gender and negative
affectivity10. The former was explained on a psychobi-
ological basis (basically as an interaction between bio-
logical features and cultural factors), while the latter
was understood as a special cognitive bias11, 12.
Somatosensory amplification (SSA), the proneness
to experience somatic sensation as intense, noxious,
and disturbing, is associated with both symptom
reporting and negative affect13. As it is also linked to
body focus, SSA was formerly conceptualized as a
blend of body focused attention and negative affect (or
anxiety) which leads to the enhancement and misinter-
pretation of body signals13, 14. Recently, it has been
suggested that sensitivity to threats to the integrity of
the body would be a better explanation15, and SSA is
not characterized by higher levels of sustained atten-
tion16. The role of SSA in nocebo related symptom
reports was demonstrated17. Moreover, SSA was asso-
ciated with IEI attributed to electromagnetic fields
(IEI-EMF) and predicted symptom reports in both
actual and sham electromagnetic fields9, 18.
Another trait-like characteristic reliably associat-
ed with symptom reports is absorption. Absorption is
the tendency to become immersed in external (senso-
ry) and internal (memories, imagination) experiences
which often leads to altered states of consciousness19.
Its most important feature is “total attention”, i.e.
when the available representational capacity is
entirely dedicated to experiencing and modelling the
object in focus19. In consequence, the experience or
sensation in focus will be amplified at the expense of
other representations. One can also be absorbed in
neutral body sensations, such as breathing, as well as
symptoms19, 20. Thus, absorption tendency might play
a role in experiencing and reporting of symptoms 8.
In empirical research, absorption was associated with
various forms of IEI21, 22.
According to the empirical findings from studies
where SSA and absorption were assessed simulta-
neously, the two traits are not (r = 0.15)23 or only
weakly (r = 0.25-0.26, p < 0.05)21, 24 connected with
each other. This raises the possibility that they
might independently contribute to symptom re -
ports. Moreover, their interaction is also possible,
i.e. those with high levels on both constructs would
show disproportionately more symptoms.
In the current study, six hypotheses were tested
as follows. It was expected that both SSA and
absorption would be independently associated with
somatic symptoms (H1 and H2, respectively).
Moreover, their interaction was also assumed (H3).
Similarly, the independent contribution of SSA
(H4) and absorption (H5) to IEI-EMF and their
interaction (H6) were also hypothesized.
Method
PARTICIPANTS
The questionnaires were completed on-line in
Hungarian. Participants were undergraduate univer-
sity students (N = 506; age: 20.1±1.67 yrs; 22.8%
female) following studies in economics or engi-
neering at Budapest University of Technology and
Economics. They received no reward for their par-
ticipation. The study was approved by the Research
Ethical Committee of the university (Approval Nr.:
2016/077), participants signed an informed consent
form before completing the questionnaires.
QUESTIONNAIRES 
Negative affect (NA), the general dimension of sub-
jective distress and unpleasurable engagement, was
assessed using the NA scale of Positive and Negative
Affect Schedule (PANAS)25. The NA scale consists
of ten items, which are evaluated on a 5-point Likert
scale (1: not at all ... 5: extremely) with respect to the
last 4 weeks. Higher total scores refer to higher lev-
els of NA. Internal consistency (Cronbach’s α) of the
NA scale in the present study was 0.84.
The prevalence and intensity of subjective somat-
ic symptoms were assessed using the Patient Health
Questionnaire Somatic Symptom Severity Scale
(PHQ-15)2. The PHQ-15 is a 15-item scale designed
to measure the prevalence of the most common body
symptoms on a 3-point Likert scale (0: not bothered
at all ... 2: bothered a lot) with respect to the last 2
weeks; it was also proposed as a diagnostic tool for a
new and broader category of somatoform disorders.
The Hungarian version showed good psychometric
properties in previous studies24, its Cronbach’s α
coefficient was 0.76 in the present study.
Somatosensory amplification, i.e., the tendency
to experience somatic sensation as intense, noxious,
and disturbing, was measured using the
Somatosensory Amplification Scale (SSAS)13, 26.
The SSAS is a 10-item scale, items are rated on a 5-
point Likert scale (1: not at all ... 5: extremely).
Higher scores refer to higher levels of amplification
tendency. Internal consistency of scale was 0.67 in
the present study.
Absorption, i.e. the openness to absorbing and
self-altering experiences, was assessed using the
Tellegen Absorption Scale (TAS)19, 24. The scale
con sists of 34 items rated in a binary (yes or no)
scale; higher scores indicate higher absorption
tendency. Cronbach’s α coefficient was 0.86 in the
present study.
STATISTICAL ANALYSIS 
Statistical analysis was carried out using the SPSS
v21 software. Variables’ associations were estimated
by Pearson-correlation. To analyze their hypothe-
sized interactions, the SSAS and TAS scores were
centered (i.e. the respective mean was subtracted
from the individual scores for all participants), and an
interaction term was calculated as the product of the
two centered values. Hypothesis 1 and 2 were
checked using multiple linear regression analysis
with PHQ-15 score as criterion variable. Predictor
variables were entered using the ENTER method in
three steps: (Step 1) gender and negative affect as
control variables, (Step 2) SSAS and TAS scores, and
(Step 3) the interaction term. Hypothesis 3 and 4 were
investigated with a binary logistic regression analysis
with IEI-EMF score as criterion variable. Predictor
variables were entered using the ENTER method in
three steps: (Step 1) gender, negative affect, and
PHQ-15 score as control variables, (Step 2) SSAS
and TAS scores, and (Step 3) the interaction term.
Results
Descriptive statistics and correlation coefficients
are presented in Table 1. Absorption showed weak
connections with SSAS, NA, and PHQ-15 scores.
Similarly, SSA was weakly associated with NA and
PHQ-scores. 10.5% of participants (53 individuals)
categorized themselves as being hypersensitive to
electromagnetic fields.
In the multiple linear regression analysis, both
SSAS and TAS scores significantly contributed to
somatic symptom score even after controlling for
gender and negative affect. However, their interac-
tion term was not significant. The final equation
explained 34.7% of the total variance (p < 0.001)
(for details, see Table 2).
Concerning IEI-EMF, the significant contributions
of both SSA and absorption were found in the binary
logistic regression equation after controlling for gen-
der, negative affect, and somatic symptoms. Similar
to the previous analysis, the interaction term proved
to be non-significant (for details, see Table 3).
Discussion
In a cross-sectional study with the participation of 506
young healthy adults, somatosensory amplification
and absorption independently contributed to somatic
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Table 1. Descriptive statistics (mean±standard deviation values) of and Pearson correlation coefficients between the
assessed variables (n = 506)
M±SD Somatosensory Negative affect Somatic symptoms
amplification
Absorption 17.14±6.770 0.26*** 0.11* 0.25***
Somatosensory amplification 27.28±5.569 0.35*** 0.37***
Negative affect 20.98±6.264 – 0.46***
Somatic symptoms 6.19±4.23 – – –
Note: * : p < 0.05; ***: p < 0.001
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symptoms and IEI-EMF. However, their interaction
was not supported by the analysis in either case.
Concerning subjective somatic symptoms, both
female gender and higher levels of negative affect
showed a significant contribution. These findings are
in accordance with previous empirical results and
models of symptom perception10, 27. In line with our
research hypothesis, both somatosensory amplifica-
tion and absorption contributed to symptom reports
even after controlling for the aforementioned vari-
ables. For SSA, this finding supports the notion that,
contrary to past proposals28, the construct is not equal
to negative affect and has additional explanatory
power in the understanding of symptom reports15.
Although absorption showed a weak association with
negative affect, SSA, and symptom reports in the
correlation analysis, its contribution to symptoms
remained significant after controlling for the former
two constructs. This supports the idea that the under-
lying psychological mechanisms are different: SSA
represents a primary (automatic) evaluation process,
while absorption refers to a non-evaluative submer-
sion in the somatic experience. The lack of interac-
tion between the two constructs is also in accordance
with this concept, as the above described psycholog-
ical mechanisms are rather incompatible with each
other. In our view, high levels of absorption reflect a
special information-processing style favouring emo-
tionally- and perceptually-driven, associative pro ces -
ses over conventional, verbally structured evaluative
processes. This way, absorption can similarly ampli-
fy positive and negative experiences depending on
the content of the representation. On the other hand,
SSA reflects “categorical” interpretations of mainly
adverse, bodily sensations. In this sense, the content
of the representation (i.e. bodily sensations) is funda-
mental and determines the adverse experiences that
are measured by SSA.
As hypothesized, SSA and absorption also con-
tributed to IEI-EMF even after controlling for
symptoms, the most salient feature of the condition.
IEI-EMF refers to a functional somatic syndrome
(i.e. a characteristic pattern of symptoms that is
attributed to a well-defined environmental factor),
which appears to be more serious and threatening
than individual symptoms. Therefore, its associa-
tion with SSA after partialling out symptoms can be
explained by the threat perception approach15.
Concerning absorption, it was proposed that elec-
tromagnetic hypersensitivity can be considered as
an overvalued idea, i.e. a strong preoccupation (still
not a delusion) that is not supported by available
evidence29. As attention can be occupied with inter-
nal images and fantasies, the overvalued idea
approach can explain the finding that absorption
remains connected with IEI-EMF even after con-
trolling for symptoms.
Understanding the psychological factors underly-
ing symptom reports and electromagnetic hypersen-
sitivity might also contribute to the development of
treatment protocols. For instance, the identification
of the role of somatosensory amplification in rela-
tion to adverse experiences and false beliefs could
be crucial to the development of personalized cogni-
Table 2. Regression coefficients in the three steps of the multiple linear regression analysis with somatic symptom score as
criterion variable
Step 1 Step 2 Step 3
R2 = 0.296 ΔR2 = 0.050 ΔR2 = 0.002
p < 0.001 p < 0.001 p = 0.223
B ± SE 95% CI Standar- B ± SE 95% CI Standar- B ± SE 95% CI Standar- 
dized β dized β dized β
Gender 2.993±0.381 2.244– 0.297*** 2.548±0.376 1.810– 0.253*** 2.545±0.375 1.807– 0.252***
3.742 3.286 3.282
Negative 0.279±0.026 0.229– 0.413*** 0.234±0.026 0.182– 0.346*** 0.234±0.026 0.182– 0.346***
affect 0.329 0.285 0.285
Somatosen- – – 0.129±0.030 0.070– 0.170*** 0.132±0.030 0.072– 0.174***
sory amp- 0.189 0.192
lification
Absorption – – 0.080±0.024 0.034– 0.128** 0.079±0.024 0.033– 0.126**
0.127 0.125




Note: ** : p < 0.01; ***: p < 0.001
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tive behavior therapies that focus on the correction
of maladaptive schemas and automatic negative
evaluations. Similarly, a patient prone to absorption
might benefit from treatments using guided imagery
and positive suggestions.
The current study has shortcomings that limit its
generalizability. Most importantly, a non-represen-
tative and special sample (university students) was
used. Second, no conclusions can be drown about
causality due to its cross-sectional design. Finally,
the assessment of IEI-EMF with only a single yes-
or-no question is also criticized30.
Keeping these limitations in mind, this is the first
study that assesses SSA and absorption simultane-
ously in the context of symptom reports and IEI-
EMF. The findings indicate that very different psy-
chological mechanisms can lie behind both phe-
nomena. Thus, their etiology and phenomenology
can be heterogeneous as well.
Conclusion
Somatosensory amplification and absorption inde-
pendently contribute to symptom reports and elec-
tromagnetic hypersensitivity. This suggest that the
underlying psychological mechanisms might also
be heterogeneous.
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Table 3. Regression coefficients in the three steps of the binary logistic regression analysis with IEI-EMF as criterion
variable
Step 1 Step 2 Step 3
Nagelkerke R2 = 0.056 Nagelkerke R2 = 0.134 Nagelkerke R2 = 0.134
p = 0.003 p < 0.001 p < 0.001
B ± SE OR (95% CI) B ± SE OR (95% CI) B ± SE OR (95% CI)
Gender 0.265±0.345 1.304 0.127±0.353 1.135 0.128±0.353 1.136
(.663–2.563) (0.568–2.266) (0.569–2.271)
Negative affect 0.032±0.025 1.033 0.022±0.027 1.022 0.022±0.027 1.022 
(.983–)1.086 (0.970–1.077) (0.970–1.077)
Somatic symptoms 0.076±0.037 1.078* 0.031±0.039 1.031 0.030±0.039 1.031 
(1.003–1.160) (0.955–1.113) (0.954–1.113)
Somatosensory – – 0.079±0.031 1.082* 0.076±0.032 1.079* 
amplification (1.019–1.149) (1.013–1.150)
Absorption – – 0.076±0.024 1.079** 0.074±0.026 1.077** 
(1.030–1.131) (1.024–1.133)
Somatosensory – – – 0.001±0.004 1.001 
amplification (0.993–1.009)
x absorption
Note: IEI-EMF: idiopathic environmental intolerance attributed to electromagnetic fields; * : p < 0.05; **: p < 0.01
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